What Has Been the Growth of the Cancer Supportive Care Products Market So Far?
The cancer supportive care products market has seen considerable growth due to a variety of factors.
• The cancer supportive care products market has grown strongly in recent years. It will increase from $21.56 billion in 2024 to $22.65 billion in 2025, at a compound annual growth rate (CAGR) of 5.1%.
Growth factors include rising cancer incidence, increased awareness, better healthcare infrastructure, a growing elderly population, and early detection advancements.
How Will the Cancer Supportive Care Products Market?
The cancer supportive care products market is expected to maintain its strong growth trajectory in upcoming years.
• The cancer supportive care products market is forecasted to reach $27.32 billion by 2029, growing at a CAGR of 4.8%.
Factors contributing to this growth include the rising cancer prevalence, patient-focused care, growing investment in cancer research, a focus on personalized medicine, and higher cancer survival rates. Trends include technological innovations, new drug delivery systems, personalized care approaches, biodegradable product development, and novel drug formulations.
Which Factors Are Boosting Growth In The Cancer Supportive Care Products Market?
The growing incidence of cancer is expected to stimulate the growth of the cancer supportive care products market. As more individuals are diagnosed with cancer, the need for supportive care products like pain management tools and nutritional supplements is rising. The American Cancer Society projected a 7.2% increase in oral cancer cases in the U.S. in 2024, boosting demand for these products.
What Key Areas Define The Segmentation Of The Global Cancer Supportive Care Products Market?
The cancer supportive care products market covered in this report is segmented –
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs, Anti-Infective, Anti-Emetics, Monoclonal Antibodies, Erythropoietin Stimulating Agents, Opioid Analgesics, Bisphosphonates, Granulocyte Colony Stimulating Factor
2) By Indication: Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukemia, Ovary Cancer, Melanoma Cancer, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies
Subsegments
1) By Nonsteroidal Anti-Inflammatory Drugs (Nsaids): Ibuprofen, Aspirin, Naproxen
2) By Anti-Infective: Antibiotics, Antifungal Drugs, Antiviral Drugs
3) By Anti-Emetics: 5-Ht3 Antagonists (Ondansetron), Nk1 Antagonists (Aprepitant), Corticosteroids (Dexamethasone)
4) By Monoclonal Antibodies: Rituximab, Trastuzumab, Bevacizumab
5) By Erythropoietin Stimulating Agents: Epoetin Alfa, Darbepoetin Alfa
6) By Opioid Analgesics: Morphine, Fentanyl, Oxycodone
7) By Bisphosphonates: Zoledronic Acid, Pamidronate, Ibandronate
8) By Granulocyte Colony Stimulating Factor: Filgrastim, Pegfilgrastim
Pre-Book The Cancer Supportive Care Products Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Cancer Supportive Care Products Market?
In the cancer supportive care products market, companies are advancing treatment options like radioligand therapy (RLT) platforms to improve efficacy and reduce side effects. For example, in May 2022, Novartis AG, a Switzerland-based company, received FDA approval for Pluvicto, a targeted radioligand therapy for treating prostate cancer. This therapy uses a radiolabeled molecule to target cancer cells, delivering localized radiation to treat metastatic castration-resistant prostate cancer (mCRPC) while sparing healthy tissue.
Who Are the Key Players In The Cancer Supportive Care Products Market?
Major companies operating in the cancer supportive care products market are:
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• AbbVie Inc.
• Bayer AG
• Abbott Laboratories
• Novartis AG
• GlaxoSmithKline plc
• Amgen Inc.
• Becton Dickinson and Company
• Teva Pharmaceutical Industries Limited
• Baxter International Inc.
• Daiichi Sankyo Company Limited
• Agilent Technologies Inc.
• Hologic Inc.
• Illumina Inc.
• Kyowa Hakko Kirin Co. Ltd.
• QIAGEN N.V.
• Exelixis Inc.
• Fagron Group B.V.
• Tessa Therapeutics Pte Ltd.
• Mirati Therapeutics Inc.
• APR Applied Pharma Science Research S.A.
• Acacia Pharma Ltd.
• Arquer Diagnostics Ltd.
What Is The Most Dominant Region In The Cancer Supportive Care Products Market?
North America was the largest region in the cancer supportive care products market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer supportive care products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
